Is Kratom an Opioid? The Answer Is Complicated
The Question Everyone Asks
"Is kratom an opioid?" It's one of the most googled kratom questions, and the answer you get depends entirely on who you ask. Kratom vendors will tell you absolutely not — it's a plant, not a drug. Government agencies like the FDA have called it an opioid. The truth, as usual, is more nuanced than either side wants to admit.
Let's break it down honestly.
The Pharmacological Answer
From a strict pharmacological perspective, kratom's primary alkaloids — mitragynine and 7-hydroxymitragynine — are opioid receptor agonists. They bind to and activate the same mu-opioid receptors that morphine, oxycodone, and heroin do.
This is not debatable. It's been demonstrated in receptor binding studies, confirmed in animal models, and is consistent with kratom's effects in humans: pain relief, euphoria, sedation at higher doses, and — critically — tolerance and physical dependence with regular use.
By the pharmacological definition, kratom contains opioid compounds. Full stop.
But It's Not That Simple
Here's where it gets more interesting. Kratom's alkaloids are atypical opioids — they don't behave exactly like classical opioids in several important ways:
Partial Agonism
Mitragynine is a partial agonist at the mu-opioid receptor, meaning it activates the receptor but not to the same degree as full agonists like morphine. Think of it as pressing the gas pedal to 60% instead of 100%. This is part of why kratom's effects are milder and why fatal respiratory depression from kratom alone is extremely rare.
Multi-Receptor Activity
Unlike most opioids, kratom alkaloids also interact with serotonergic, adrenergic, and dopaminergic systems. This gives kratom a more complex effect profile — the stimulant properties at low doses, the mood effects, the anxiety reduction — that pure opioids don't produce. Our article on how kratom affects the brain covers this in detail.
Biased Agonism
Recent research suggests mitragynine may be a "biased agonist" — meaning it preferentially activates certain intracellular signaling pathways (G-protein) over others (beta-arrestin). This is significant because beta-arrestin signaling is associated with respiratory depression and constipation. Biased agonism could explain why kratom causes less respiratory depression than classical opioids.
Not Derived From Opium
Technically, the word "opiate" refers specifically to compounds derived from the opium poppy (morphine, codeine, thebaine). "Opioid" is broader — it includes any substance that acts on opioid receptors, whether natural, semi-synthetic, or synthetic. Kratom is neither an opiate nor a classical opioid, but it is an opioid receptor agonist.
Why the Classification Matters
This isn't just an academic debate. How kratom is classified has real consequences:
For Legal Status
If kratom is classified as an opioid by regulators, it becomes much easier to schedule it as a controlled substance. The DEA attempted this in 2016 and was pushed back by public outcry. The classification question is central to ongoing legal battles over kratom.
For Medical Treatment
If you go to a doctor or emergency room and say "I'm dependent on kratom," their response may depend on whether they view it as an opioid issue. Doctors who understand the opioid receptor connection are more likely to offer appropriate treatments. Those who dismiss it as "just a plant" may not take your withdrawal seriously.
For Your Own Understanding
If you're using kratom daily and telling yourself it's not an opioid, so it can't cause "real" dependence — that's a dangerous misunderstanding. The mechanism of dependence is the same regardless of what you call the substance. Your opioid receptors don't care about labels.
The Comparison to Other Opioids
How does kratom stack up against classical opioids? Here's a rough comparison:
| Factor | Kratom (Plain Leaf) | Prescription Opioids | Heroin |
|---|---|---|---|
| Receptor binding | Partial agonist | Full agonist | Full agonist |
| Respiratory depression risk | Very low | Significant | High |
| Dependence potential | Moderate | High | Very high |
| Withdrawal severity | Mild-moderate | Moderate-severe | Severe |
| Withdrawal duration | 1-2 weeks | 1-4 weeks | 1-2 weeks |
| Overdose risk (alone) | Very low | Significant | High |
| Legal status | Mostly legal | Prescription only | Illegal |
This comparison isn't meant to minimize kratom's risks. It's meant to provide context. Kratom is genuinely less dangerous than classical opioids on most measures — but "less dangerous than heroin" is a low bar, and kratom dependence is still a serious problem that affects thousands of people.
What About Kratom Extracts?
It's worth noting that kratom extracts — concentrated products like OPMS shots — push much closer to classical opioid territory. They contain dramatically higher concentrations of 7-hydroxymitragynine, which is a more potent opioid agonist than mitragynine. The "kratom is mild and safe" argument holds up much less well when you're talking about extracts.
The Honest Bottom Line
Is kratom an opioid? It contains compounds that act on opioid receptors, produce opioid-like effects, and cause opioid-type dependence and withdrawal. By any functional definition, it behaves like an atypical opioid.
Is it identical to classical opioids? No. It's pharmacologically distinct in ways that make it genuinely less dangerous in some respects — particularly regarding respiratory depression and overdose risk.
Does the label matter for you personally? Only insofar as it helps you understand what you're dealing with. If you're dependent on kratom, the path forward is the same regardless of terminology: understand your tolerance, make a taper plan, and take it one day at a time.
The information on this website is for educational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.